openPR Logo
Press release

Exocrine Pancreatic Insufficiency (EPI) Therapeutics- Pipeline Analysis

Exocrine Pancreatic Insufficiency (EPI) Therapeutics-

Exocrine pancreatic insufficiency (EPI) is the inability of pancreas to produce enough enzymes for the proper breakdown and absorption of nutrients. The common causes of EPI are damage to pancreas, inflammation of pancreas, pancreatic surgery, and inherited disorders like Crohn’s disease and celiac disease.

Download the sample report at: https://www.pharmaproff.com/request-sample/1024

Some symptoms observed during EPI are pain or tenderness in belly, bad-smelling bowel movements, gas, diarrhea and feeling of fullness. EPI can be treated by pancreatic enzyme replacement therapy (PERT) and medications.

Get the detailed analysis at: https://www.pharmaproff.com/report/epi-therapeutics-pipeline-analysis

This disease can be prevented by eating six small meals a day, avoiding alcohol, taking vitamins and following a healthy diet. Cilian AG is in the process of developing Cilase as an orally active substance for the treatment of EPI in humans. Other than this AzurRx BioPharma Inc. is also in the process of developing MS1819 for the treating EPI.

Make enquiry before purchase at: https://www.pharmaproff.com/enquiry/1024

• The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials.
• Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

About Us:
Pharma Proff, is a frontline market intelligence and consulting solutions provider catering to the information and data needs of burgeoning sectors across the world, including pharmaceutical and healthcare. With meticulously curated research reports on the industry landscape, we empower companies in the healthcare and pharmaceutical sectors to make informed business decisions and base their marketing strategies with astuteness.

Contact:
Pharma Proff
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@pharmaproff.com
Web: https://www.pharmaproff.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Exocrine Pancreatic Insufficiency (EPI) Therapeutics- Pipeline Analysis here

News-ID: 1750389 • Views: 454

More Releases for EPI

Global Epi Wafer Market 2018 - Nichia, EpiWorks, Norstel, OMMIC
Eminent Market, recently published a detailed market research study focused on the "Epi Wafer Market" across the global, regional and country level. The report provides 360° analysis of "Epi Wafer Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Epi Wafer industry, and estimates the future trend of Epi Wafer market on
Epitaxial (Epi) Wafer Market Investment Research Report 2025
Epitaxy is a method used to grow or lay a single crystalline film or layer over a crystalline-based semiconductor surface or substrate. The deposited substance must have a definite acclimatization with regard to the crystal-based semiconductor substrate. Moreover, Chip developers applies either molten or vapor based foundations to produce such epitaxial over layers. An epitaxial wafer is a wafer of semiconducting substrate made by epitaxial growth for application in microelectronics,
Global Epi Wafer Market Report Analysis and Forecast 2017
ReportsWeb.com has announced the addition of the “Global Epi Wafer Market Research Report 2017-2022” The report focuses on global major leading industry players with information such as company profiles, product picture and specification. The Global Epi Wafer Market Professional Survey Report 2017 is a professional and in-depth study on the current state of the Epi Wafer market. Annual estimates and forecasts are provided for the period 2017 through 2022. Also, a
Epi Wafer Market 2017 - GlobalWafers, Nichia, EpiWorks
Apex Research, recently published a detailed market research study focused on the "Epi Wafer Market" across the global, regional and country level. The report provides 360° analysis of "Epi Wafer Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Epi Wafer industry, and estimates the future trend of Epi Wafer market on
Epitaxial (Epi) Wafer Market 2017- ASM International, EpiWorks, Jenoptik
Marketreports.biz, recently published a detailed market research study focused on the "Epitaxial (Epi) Wafer Market" across the global, regional and country level. The report provides 360° analysis of "Epitaxial (Epi) Wafer Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Epitaxial (Epi) Wafer industry, and estimates the future trend of Epitaxial
Epi Wafer Market to Hit 11.65% to 2021
For overview analysis, the report introduces Epi Wafer Market basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc. Marketsizeforecasters.com adds new global Epi Wafer market: report that lists top active companies as EpiWorks, GlobalWafers, Nichia, and SHOWA DENKO K.K. Other Prominent Vendors in the market are: Century Epitech, Desert Silicon, ELECTRONICS AND MATERIALS, Intelligent Epitaxy Technology, IQE, Jenoptik, MOSPEC Semiconductor, Norstel, OMMIC, Roditi, Silicon